Fauna Bio Inc. has nominated Faun-1083 as its first development candidate, for the treatment of heart failure with preserved ejection fraction (HFpEF). Faun-1083 is a novel small-molecule therapeutic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback